Co-ordinate expression of activin A and its type I receptor mRNAs during phorbol ester-induced differentiation of human K562 erythroleukemia cells

Mol Cell Endocrinol. 1999 Jul 20;153(1-2):137-45. doi: 10.1016/s0303-7207(99)00074-x.

Abstract

Activins were originally isolated based on their ability to stimulate follicle-stimulating hormone secretion but later they have been shown to regulate a number of different cellular functions such as nerve cell survival, mesoderm induction during early embryogenesis as well as hematopoiesis. We studied the regulation of activin A, a homodimer of betaA-subunits, mRNA and protein in K562 erythroleukemia cells, which are known to be induced toward the erythroid lineage in response to activin or TGF-beta or toward the megakaryocytic lineage by the phorbol ester protein kinase C activator 12-O-tetradecanoylphorbol-13-acetate (TPA). Here we show by Northern blot analysis as well as by Western and ligand blotting that TPA strongly promotes activin betaA-subunit mRNA and activin A protein expression in K562 cells in time- and concentration dependent manner. In contrast, neither activin A nor TGF-beta induced betaA-subunit mRNA expression during erythroid differentiation in K562 cells. Interestingly, whereas activin type II receptors are not regulated during K562 cell differentiation (Hilden et al. (1994) Blood 83, 2163-2170), we now show that the activin type I and IB receptor mRNAs are clearly induced by TPA but not by activin or TGF-beta. We also show that the inducing effect of TPA on expression of activin betaA-subunit mRNA is potentiated by the protein kinase A activator 8-bromo-cAMP. We conclude that activin A and its type I receptors appear to be co-ordinately up-regulated during megakaryocytic differentiation of K562 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Activin Receptors
  • Activins
  • Blotting, Southern
  • Cell Differentiation*
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dimerization
  • Drug Synergism
  • Enzyme Activation / drug effects
  • Gene Expression*
  • Humans
  • Inhibins / genetics*
  • K562 Cells / cytology
  • K562 Cells / metabolism*
  • Megakaryocytes / cytology
  • RNA, Messenger / metabolism
  • Receptors, Growth Factor / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transforming Growth Factor beta / pharmacology

Substances

  • RNA, Messenger
  • Receptors, Growth Factor
  • Transforming Growth Factor beta
  • Activins
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Inhibins
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases
  • Activin Receptors
  • Tetradecanoylphorbol Acetate